Pediatric Brain Tumor Market Research Report - Global Forecast till 2027

Pediatric Brain Tumor Market Information, By Types (Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, and others), By Diagnosis (Imaging Tests, Brain Or Spinal Cord Tumor Biopsy, and others), By Treatment, By End User- Global Forecast Till 2027

ID: MRFR/Pharma/2458-HCR | February 2021 | Region: Global | 76 pages

Please note that the assessment period of report has been updated from 2016- 2023 to 2020-2027. Cordially fill Sample form for updated data.

Market synopsis of Global Pediatric Brain Tumor Market:
Market Scenario:

Pediatric brain tumor is uncontrolled or abnormal growth of normal cell in the brain in children. Brain tumors mainly are of two types, cancerous (malignant) and noncancerous (benign). It is second most common type of cancer in children and it comprise about 25% of childhood cancer.
The cases of pediatric tumors are increasing globally that leading the growth of the market. Advanced diagnostic technology and new treatments are also major driving forces of the market. Rising healthcare infrastructure, extended insurance cover, government initiatives, and emerging economies are driving the market. Rising funding for R&D and clinical trials as well as FDA approvals are also major growth factors for global pediatric brain tumor market.
The global pediatric brain tumor market is growing at the CAGR of ~4.1% during the forecast period and expected to reach US$ 1659.4 million by 2023.
Study objectives of Global Pediatric brain tumor market:

  • To provide detailed analysis of the global pediatric brain tumor market structure with historical and forecast revenue for the next 6 years of the various segments and sub-segments of the pediatric brain tumor market

  • To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of the global pediatric brain tumor market

  • To provide analysis of the market with respect to four main geographies and their countries - America, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detailed analysis of the market segmented by types, diagnosis, treatment, end user and its sub-segments.

  • To provide a detailed analysis of global pediatric brain tumor market mainly based on Value chain analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.

  • To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global pediatric brain tumor market

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the pediatric brain tumor market 

Pediatric Brain Tumor Market


Key Players for Global Pediatric Brain Tumor Market:

Some of the key players in this market are: Abbott. (US), AbbVie Inc. (US), Akorn, Inc. (US), Agios, Inc. (US), Baxter (US) , Bayer AG (US), Epizyme, Inc. (US), Novartis AG (Switzerland), Mylan N.V. (US), and others


Global pediatric brain tumor market has been segmented on the basis of types which comprises of gliomas, mixed neuronal-glial tumors, embryonal tumors, choroid plexus papilloma/carcinoma, non-neuroepithelial tissue tumors, meningeal tumors, and others. Gliomas is further sub-segmented into astrocytoma, malignant gliomas, and others. Mixed neuronal-glial tumors are further sub-segmented into ganglioglioma, subependymal giant cell tumor, pleomorphic xanthoastrocytoma, and others. Embryonal tumors are further sub-segmented into primitive neuroectodermal tumor (PNET), atypical teratoid/rhabdoid tumor, and others. Tumors arising from non-neuroepithelial tissue are further sub-segmented into craniopharyngioma, pineal region tumors, and others.
On the basis of diagnosis, it is segmented into physical exam, Imaging tests, brain or spinal cord tumor biopsy, Llmbar puncture (spinal tap), blood and urine tests, and others. Imaging tests are further sub-segmented into Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan, Angiogram, and others. Magnetic Resonance Imaging (MRI) scan is further sub-segmented into Magnetic Resonance Angiography (MRA), Magnetic Resonance Spectroscopy (MRS), Magnetic resonance perfusion, Functional MRI (fMRI), and others. Brain or spinal cord tumor biopsy is further sub-segmented into Stereotactic needle biopsy, Craniotomy, and other.
On the basis of treatment, the market has been segmented into surgery, therapies, drug treatment, and others. Surgery is further sub-segmented into surgical biopsy, resection (removal), Shunt placement/revision, and others. Therapies includes Radiation therapy, Chemotherapy, Targeted therapy, and others. Chemotherapy includes Carboplatin, Carmustine (BCNU), Cisplatin, Cyclophosphamide, Etoposide, Lomustine (CCNU), Methotrexate, Temozolomide, Thiotepa, Vincristine, and others. Drug treatment is further sub-segmented into Corticosteroids, Anti-seizure drugs (anti-epileptics), Hormones, and others. 
On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.

Research Methodology:
Pediatric Brain Tumor Market-

Regional analysis of Global Pediatric Brain Tumor Market:
Considering the global scenario of the market, North America holds the largest market share owing to various factors such as increasing cases of pediatric brain tumors and related medical complications. Europe is the second largest market where the countries like Germany and UK are holding the largest market share. In 2014, about 10,000 new cases of pediatric brain tumors were observed. New cases of pediatric brain tumor are rapidly growing in Asia Pacific region. Additionally, improving healthcare sector, government initiatives to improve public health and rising healthcare spending are driving the growth for Asia Pacific pediatric brain tumor market. Due to low knowledge of disease, limited availability of medical facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.

The report for Global Pediatric Brain Tumor Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

Intended Audience:

  • Pediatric brain tumor diagnostic devices manufacturers

  • Pediatric brain tumor medicine and treatment providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors 

1. Report Prologue
2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation
3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model
4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators
5. Market Factor analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others
6. Global Pediatric brain tumor Market by Types

6.1 Gliomas

6.1.1 Astrocytoma

6.1.2 Malignant Gliomas

6.1.3 Others

6.2 Mixed neuronal-glial tumors

6.2.1 Ganglioglioma

6.2.2 Subependymal giant cell tumor

6.2.3 Pleomorphic xanthoastrocytoma

6.2.4 Others

6.3 Embryonal tumors

6.3.1 Primitive Neuroectodermal Tumor (PNET)

6.3.2 Atypical teratoid/Rhabdoid tumor

6.3.3 Others

6.4 Choroid plexus papilloma/Carcinoma

6.5 Tumors arising from non-neuroepithelial tissue

6.5.1 Craniopharyngioma

6.5.2 Pineal region tumors

6.5.3 Other

6.6 Meningeal tumors

6.7 Others
7. Global Pediatric brain tumor Market by Diagnosis

7.1 Physical Exam

7.2 Imaging tests

7.2.1 Magnetic resonance imaging (MRI) scan Magnetic resonance angiography (MRA) Magnetic resonance spectroscopy (MRS) Magnetic resonance perfusion Functional MRI (fMRI) Others

7.2.2. Computed tomography (CT) scan

7.2.3 Positron emission tomography (PET) scan

7.2.4 Angiogram

7.2.5 Others

7.3 Brain or spinal cord tumor biopsy

7.3.1 Stereotactic needle biopsy

7.3.2 Craniotomy

7.3.3 Others

7.4 Lumbar puncture (spinal tap)

7.5 Blood and urine tests

7.6 Others
8. Global Pediatric brain tumor Market by Treatment

8.1 Surgery

8.1.1 Surgical biopsy

8.1.2 Resection (removal)

8.1.3 Shunt placement/revision

8.1.4 Others

8.2 Therapies

8.2.1 Radiation therapy

8.2.2 Chemotherapy Carboplatin Carmustine (BCNU) Cisplatin Cyclophosphamide Etoposide Lomustine (CCNU) Methotrexate Temozolomide Thiotepa Vincristine Others

8.2.3 Targeted therapy

8.2.4 Others

8.4 Others
9. Global Pediatric brain tumor Market by End User

9.1 Hospitals and clinics

9.2 Medical Research centers

9.3 Academic institutes

9.4 Others
10. Global Pediatric brain tumor Market by Region

10.1 Introduction

10.2 America

10.2.1 North America The US Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe Germany France Italy Spain UK Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia

10.4.1 China

10.4.2 India

10.4.3 Japan

10.4.4 South Korea

10.4.5 Rest of Asia

10.5 Pacific

10.6 Middle East and Africa

10.6.1 UAE

10.6.2 Saudi Arabia

10.6.3 Egypt

10.6.4 Rest of Middle East and Africa
11. Competitive landscape
12. Company profile
13. Conclusion

13.1 Key findings

13.1.1 From CEO’s viewpoint

13.1.2 Unmet needs of the market

13.2 Key companies to watch

13.3 Prediction of Pediatric brain tumor Market
14. Appendix